Cerebrospinal fluid penetration of tigecycline

Today very little is known about tigecycline penetration into cerebrospinal fluid (CSF). We report, in a clinical setting, tigecycline concentration, and the area under concentration-time curve (AUC) - both in blood and in CSF - of a patient affected by ventriculo-atrial shunt (VAS) infection due t...

Full description

Bibliographic Details
Main Authors: Carlo Pallotto, Maurizio Fiorio, Antonio D'Avolio, Alessio Sgrelli, Franco Baldelli, Giovanni Di Perri, Giuseppe Vittorio Luigi De Socio
Format: Article
Language:English
Published: PAGEPress Publications 2014-08-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://mjhid.org/index.php/mjhid/article/view/1878
_version_ 1826911376717643776
author Carlo Pallotto
Maurizio Fiorio
Antonio D'Avolio
Alessio Sgrelli
Franco Baldelli
Giovanni Di Perri
Giuseppe Vittorio Luigi De Socio
author_facet Carlo Pallotto
Maurizio Fiorio
Antonio D'Avolio
Alessio Sgrelli
Franco Baldelli
Giovanni Di Perri
Giuseppe Vittorio Luigi De Socio
author_sort Carlo Pallotto
collection DOAJ
description Today very little is known about tigecycline penetration into cerebrospinal fluid (CSF). We report, in a clinical setting, tigecycline concentration, and the area under concentration-time curve (AUC) - both in blood and in CSF - of a patient affected by ventriculo-atrial shunt (VAS) infection due to Enterococcus faecium and Nocardia farcinica. At the steady state, the serum and CSF concentration of tigecycline, at through, were 49 ng/mL and 5.2 ng/mL respectively, whereas the peak concentrations were 203 ng/mL and 13.4 ng /mL, with an average ratio of CSF-to-serum concentrations (CSF/serum) of 0.079. The serum AUC0-12 value was 1361.5 h*ng/ml, the CSF AUC0-12 was 91.6 h*ng/ml and the ratio between CSF and serum AUC0-12  (CSF/serum AUC0-12) was 0.067. Despite the low tigecycline CSF concentration, the microbiological tests were all negative. Tigecycline weakly penetrates CSF.
first_indexed 2024-12-24T00:57:27Z
format Article
id doaj.art-1a4afdbe80cb4bde89110c66123533de
institution Directory Open Access Journal
issn 2035-3006
language English
last_indexed 2025-02-17T10:13:47Z
publishDate 2014-08-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj.art-1a4afdbe80cb4bde89110c66123533de2025-01-02T00:32:52ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062014-08-011Cerebrospinal fluid penetration of tigecyclineCarlo Pallotto0Maurizio Fiorio1Antonio D'Avolio2Alessio Sgrelli3Franco Baldelli4Giovanni Di Perri5Giuseppe Vittorio Luigi De Socio6Department of Infectious Diseases, “Santa Maria della Misericordia” Hospital, University of PerugiaDepartment of Infectious Diseases, “Santa Maria della Misericordia” Hospital, University of Perugia, Perugia, ItalyUnit of Infectious Diseases, University of Turin, Department of Medical Sciences, Amedeo di Savoia Hospital, Turin, ItalyDepartment of Infectious Diseases, “Santa Maria della Misericordia” Hospital, University of Perugia, Perugia, ItalyDepartment of Infectious Diseases, “Santa Maria della Misericordia” Hospital, University of Perugia, Perugia, ItalyUnit of Infectious Diseases, University of Turin, Department of Medical Sciences, Amedeo di Savoia Hospital, Turin, ItalyDepartment of Infectious Diseases, “Santa Maria della Misericordia” Hospital, University of Perugia, Perugia, ItalyToday very little is known about tigecycline penetration into cerebrospinal fluid (CSF). We report, in a clinical setting, tigecycline concentration, and the area under concentration-time curve (AUC) - both in blood and in CSF - of a patient affected by ventriculo-atrial shunt (VAS) infection due to Enterococcus faecium and Nocardia farcinica. At the steady state, the serum and CSF concentration of tigecycline, at through, were 49 ng/mL and 5.2 ng/mL respectively, whereas the peak concentrations were 203 ng/mL and 13.4 ng /mL, with an average ratio of CSF-to-serum concentrations (CSF/serum) of 0.079. The serum AUC0-12 value was 1361.5 h*ng/ml, the CSF AUC0-12 was 91.6 h*ng/ml and the ratio between CSF and serum AUC0-12  (CSF/serum AUC0-12) was 0.067. Despite the low tigecycline CSF concentration, the microbiological tests were all negative. Tigecycline weakly penetrates CSF.https://mjhid.org/index.php/mjhid/article/view/1878tigecyclineCSFpharmacokinetics
spellingShingle Carlo Pallotto
Maurizio Fiorio
Antonio D'Avolio
Alessio Sgrelli
Franco Baldelli
Giovanni Di Perri
Giuseppe Vittorio Luigi De Socio
Cerebrospinal fluid penetration of tigecycline
Mediterranean Journal of Hematology and Infectious Diseases
tigecycline
CSF
pharmacokinetics
title Cerebrospinal fluid penetration of tigecycline
title_full Cerebrospinal fluid penetration of tigecycline
title_fullStr Cerebrospinal fluid penetration of tigecycline
title_full_unstemmed Cerebrospinal fluid penetration of tigecycline
title_short Cerebrospinal fluid penetration of tigecycline
title_sort cerebrospinal fluid penetration of tigecycline
topic tigecycline
CSF
pharmacokinetics
url https://mjhid.org/index.php/mjhid/article/view/1878
work_keys_str_mv AT carlopallotto cerebrospinalfluidpenetrationoftigecycline
AT mauriziofiorio cerebrospinalfluidpenetrationoftigecycline
AT antoniodavolio cerebrospinalfluidpenetrationoftigecycline
AT alessiosgrelli cerebrospinalfluidpenetrationoftigecycline
AT francobaldelli cerebrospinalfluidpenetrationoftigecycline
AT giovannidiperri cerebrospinalfluidpenetrationoftigecycline
AT giuseppevittorioluigidesocio cerebrospinalfluidpenetrationoftigecycline